CDH1 and cancer: The high expression of these OncomiRs in clinical breast cancer tissues affects the prognosis of patients, and inhibition of their expression can reverse the EMT of TNBC cells and inhibit the proliferation and metastasis of cancer cells by up-regulating the expression of target genes PTEN, PDCD4, FOXO3a, RhoA, TRPS1 and E-cadherin [20].